IL-33 expression was elevated in muscular and serosal invasion but decreased in poorly differentiated and metastatic tumors, suggesting a dual role—potentially protective in early stages and tumor-promoting in advanced disease. This evidence concerns the gene IL33 and metastatic neoplasm.